Patent Expiry Information

Before development of a generic pharmaceutical can begin, it is necessary to identify candidate molecules. The ultimate selection is determined by such factors as global markets & therapeutic group, but the timing of the development is driven by global patent expiry dates.

The common flaw in this approach is to assume that the expiry of only one molecule patent will enable generic competition, having little regard to other patents such as those protecting polymorphs, salts, formulations uses or dosing regimens.

XIP is able to provide customised, market-specific patent expiry information that gives a more complete picture of the patent protection surrounding a particular set of molecules combined with analysis of the likely date of competition.

XIP also provides up-to date information regarding Extensions to pharmaceutical patent terms in many countries around the world, as well as analyses of the likely effects of newly introduced patent extensions.

Please contact us for more information or a quotation for these services.